MOUNTAIN VIEW, Calif., Aug. 30, 2017 /PRNewswire/ -- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions and analytics software for healthcare facilities, today announced they will present at the 12th Annual Wells Fargo Securities Healthcare Conference in Boston, MA.
Omnicell Speaker: Peter Kuipers, executive vice president & CFO
Date: Wednesday, September 6, 2017
Time: 11:25 a.m. ET
Location: Westin Boston Waterfront
Availability: The audio-webcast of the live presentation may be accessed by visiting:
Following the conference, a replay of the audio-webcast will be archived for 30 days on the Omnicell website.
Since 1992, Omnicell (NASDAQ: OMCL) has been inspired to create safer and more efficient ways to manage medications and supplies across all care settings. As a leader in medication and supply dispensing automation, central pharmacy automation, IV robotics, analytics software, and medication adherence and packaging systems, Omnicell is focused on improving care across the entire healthcare continuum—from the acute care hospital setting, to post-acute skilled nursing and long-term care facilities, to the patient's home.
Over 4,000 customers worldwide use Omnicell® automation and analytics solutions to increase operational efficiency, reduce medication errors, deliver actionable intelligence and improve patient safety.
Omnicell's innovative medication adherence solutions, used by over 32,000 institutional and retail pharmacies in North America and the United Kingdom, are designed to improve patient adherence to prescriptions, helping to reduce costly hospital readmissions.
Recent Omnicell acquisitions, including Ateb, add distinct capabilities, particularly in central pharmacy, IV robotics, and pharmacy software, creating the broadest medication management product portfolio in the industry.
View original content with multimedia:http://www.prnewswire.com/news-releases/omnicell-to-present-at-the-12th-annual-wells-fargo-securities-healthcare-conference-300511320.html
SOURCE Omnicell, Inc.